Throughout the U.S., Canada, and Europe, plasma centers generate the opportunity to provide source plasma that can be manufactured into life-saving drugs and produce patient therapies through a process called plasmapheresis. Plasmapheresis is the process by which source plasma is separated and collected from the other components of human blood. The plasma is collected from a voluntary donor and is stored onsite in state-of-the-art refrigeration units until it is shipped out for fractionation. The other components of whole blood; red blood cells, white blood cells, and platelets are then returned to the body of the donor.
Modern plasma production technology remains largely based on the manufacturing process known as fractionation, in which proteins are separated to create specific therapies for different patients. Plasma protein therapies – also known as PPTs – are individualistic, biologic medicines that are used to treat burns, shock, trauma and a variety of diseases and disorders including:
- life-threatening chronic and genetic issues
- bleeding disorders
- immune deficiencies
- pulmonary disorders
- neurological disorders
- shock and trauma
- liver cirrhosis
With the core plasma fractionation technology being unchanged for roughly 70 years there is a solid foundation to the industry. Plasma cannot be synthetically manufactured or produced so it is vital that healthy and willing volunteers continue to donate.
At Stough Development, this foundation sets the standard in our development and design of plasma centers. The designers at Barbara Stough Interiors work to create a space with donor comfort and employee safety in mind. Creating a layout that is welcoming, comfortable and clean ensures patient satisfaction and return. A space that is warm and inviting, from the minute they step into the center to when they leave, will ultimately boost employee morale and improve the center’s productivity.